Literature DB >> 8730285

Holt-Oram syndrome: a clinical genetic study.

R A Newbury-Ecob1, R Leanage, J A Raeburn, I D Young.   

Abstract

A clinical and genetic study of the Holt-Oram syndrome (HOS) has been carried out in the United Kingdom involving 55 cases designated Holt-Oram syndrome, together with their parents and sibs. Data from the clinical assessment of both familial and isolated cases were used to define the HOS phenotype and to outline the spectrum of abnormalities, especially factors affecting severity. Skeletal defects affected the upper limbs exclusively and were bilateral and asymmetrical. They ranged from minor signs such as clinodactyly, limited supination, and sloping shoulders to severe reduction deformities of the upper arm (4.5%). The radial ray was predominantly affected than the right. All affected cases showed evidence of upper limb involvement. Cardiac defects were seen in 95% of familial cases and included both atrial septal defect (ASD, 34%) and ventricular septal defect (VSD, 25%); 39% had only ECG changes. Cardiac involvement ranged from asymptomatic conduction disturbances to multiple structural defects requiring surgery in infancy. Sudden death could be caused by heart block. Inheritance was autosomal dominant with 100% penetrance and no evidence of reduced fitness. Increasing severity occurred in succeeding generations consistent with anticipation.

Entities:  

Mesh:

Year:  1996        PMID: 8730285      PMCID: PMC1050579          DOI: 10.1136/jmg.33.4.300

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  23 in total

1.  Holt-Oram syndrome.

Authors:  A S Cascos
Journal:  Acta Paediatr Scand       Date:  1967-05

2.  Anomalies associated with radial dysplasia.

Authors:  R E Carroll; D S Louis
Journal:  J Pediatr       Date:  1974-03       Impact factor: 4.406

3.  Variable expression of the Holt-Oram syndrome.

Authors:  R L Kaufman; D L Rimoin; W H McAlister; A F Hartmann
Journal:  Am J Dis Child       Date:  1974-01

4.  A girl with severe expression of the holt-oram gene.

Authors:  R J Gardner; P M Buckfield; A M Veale
Journal:  Clin Genet       Date:  1973       Impact factor: 4.438

5.  The upper limb-cardiovascular syndrome. A report of two African cases with a review of the literature.

Authors:  Y W Brans; J P Lintermans
Journal:  Am J Dis Child       Date:  1972-11

6.  Thrombocytopenia and absent radius (TAR) syndrome.

Authors:  J G Hall
Journal:  J Med Genet       Date:  1987-02       Impact factor: 6.318

7.  A population study of the VACTERL association: evidence for its etiologic heterogeneity.

Authors:  M J Khoury; J F Cordero; F Greenberg; L M James; J D Erickson
Journal:  Pediatrics       Date:  1983-05       Impact factor: 7.124

8.  The upper limb-cardiovascular syndrome. An autosomal dominant genetic effect on embryogenesis.

Authors:  K B Lewis; R A Bruce; D Baum; A G Motulsky
Journal:  JAMA       Date:  1965-09-27       Impact factor: 56.272

9.  Holt-Oram syndrome.

Authors:  A T Smith; G H Sack; G J Taylor
Journal:  J Pediatr       Date:  1979-10       Impact factor: 4.406

10.  Spectrum of anomalies in Fanconi anaemia.

Authors:  A Glanz; F C Fraser
Journal:  J Med Genet       Date:  1982-12       Impact factor: 6.318

View more
  50 in total

1.  Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome, and patients previously reported to represent thalidomide embryopathy.

Authors:  J Kohlhase; L Schubert; M Liebers; A Rauch; K Becker; S N Mohammed; R Newbury-Ecob; W Reardon
Journal:  J Med Genet       Date:  2003-07       Impact factor: 6.318

2.  Functional analysis of TBX5 missense mutations associated with Holt-Oram syndrome.

Authors:  Chun Fan; Mugen Liu; Qing Wang
Journal:  J Biol Chem       Date:  2002-12-23       Impact factor: 5.157

Review 3.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

4.  TBX5 is required for embryonic cardiac cell cycle progression.

Authors:  Sarah C Goetz; Daniel D Brown; Frank L Conlon
Journal:  Development       Date:  2006-05-25       Impact factor: 6.868

5.  An evolutionarily conserved nuclear export signal facilitates cytoplasmic localization of the Tbx5 transcription factor.

Authors:  Andre Kulisz; Hans-Georg Simon
Journal:  Mol Cell Biol       Date:  2007-12-26       Impact factor: 4.272

Review 6.  Anticipation: an old idea in new genes.

Authors:  M G McInnis
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

Review 7.  Tetralogy of Fallot with Holt-Oram syndrome: case report and review.

Authors:  Abhay Tidake; Pranil Gangurde; Zohaib Shaikh; Ajay Mahajan
Journal:  Clin Res Cardiol       Date:  2015-04-23       Impact factor: 5.460

Review 8.  Making and breaking symmetry in development, growth and disease.

Authors:  Daniel T Grimes
Journal:  Development       Date:  2019-08-15       Impact factor: 6.868

9.  Tbx5 inhibits hedgehog signaling in determination of digit identity.

Authors:  Huiting Xu; Menglan Xiang; Yushu Qin; Henghui Cheng; Duohua Chen; Qiang Fu; Ke K Zhang; Linglin Xie
Journal:  Hum Mol Genet       Date:  2020-06-03       Impact factor: 6.150

10.  Evolutionarily conserved Tbx5-Wnt2/2b pathway orchestrates cardiopulmonary development.

Authors:  Jeffrey D Steimle; Scott A Rankin; Christopher E Slagle; Jenna Bekeny; Ariel B Rydeen; Sunny Sun-Kin Chan; Junghun Kweon; Xinan H Yang; Kohta Ikegami; Rangarajan D Nadadur; Megan Rowton; Andrew D Hoffmann; Sonja Lazarevic; William Thomas; Erin A T Boyle Anderson; Marko E Horb; Luis Luna-Zurita; Robert K Ho; Michael Kyba; Bjarke Jensen; Aaron M Zorn; Frank L Conlon; Ivan P Moskowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.